US 2014/0371243 A1Published application

Medical use of a dpp-4 inhibitor

AssigneeBoehringer Ingelheim International GmbH

InventorsThomas KLEIN, Takashi NOMIYAMA, Yuichi TERAWAKI, Toshihiko YANASE

Life of this patent

Estimating the term…

Abstract

The present invention relates to the use of a certain DPP-4 inhibitor along with angioplasty or stenting, and/or to its use for treating and/or preventing restenosis from angioplasty or stenting.

Claims20

Dependent claims

A method of treating a patient who is in need of, indicated for or has undergone angioplasty and/or stenting, the method comprising administering a DPP-4 inhibitor, optionally in combination with one or more other active agents, to the patient.

Dependencies are inferred from the claim text.

Facts

Application: 14/303,852Filed 13 Jun 2014
Priority: EP 13003042.214 Jun 2013
Published: 18 Dec 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification10 codes

A61K 31/522
Purines, e.g. adenine: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A61K 31/517
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim: ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results